ROC curve analysis shows that the combination of Asprosin and NT-proBNP has higher diagnostic efficiency, suggesting that Asprosin combined with BNP can be used as a more potential biomarker for the diagnosis of HF, providing a new reference for clinical diagnosis and treatment. Here, FBN1 is linked to hydrops fetalis.